NeuroSense Therapeutics NRSN
NASDAQ NRSN
$2.44 -0.12 (-4.69%)
At close: Oct 22, 2026 · 4:00 PM EDT

NeuroSense Therapeutics (NRSN) Net Income (2021 - 2024)

Updated

NeuroSense Therapeutics (NRSN) posted Net Income of -$11.13 million for FY2025, compared with -$10.21 million in FY2024.

Analysis

NeuroSense Therapeutics (NRSN) Net Income (2021 - 2024) Analysis & Trends

Since FY2019, NeuroSense Therapeutics has reported Net Income for 7 years.

  • The FY2025 figure stands as the lowest annual Net Income in data going back to FY2019.
  • Business Quant data shows NRSN's Net Income at -$10.21 million in FY2024, -$10.11 million in FY2023, -$10.49 million in FY2022 and -$3.22 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 210.00 Mn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 3.62 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 3.26 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 2.51 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -10.50 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -248.00 Mn
10 NeuroSense Therapeutics 3.06 Mn -1.38 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -1.77 Mn
Sep 30, 2024 -2.11 Mn
Jun 30, 2024 -3.03 Mn
Mar 31, 2024 -2.99 Mn
Dec 31, 2023 -7.14 Mn
Sep 30, 2023 5.47 Mn
Jun 30, 2023 -5.74 Mn
Mar 31, 2023 -2.62 Mn
Dec 31, 2022 -288,000.00
Sep 30, 2022 -2.86 Mn
Jun 30, 2022 -3.53 Mn
Mar 31, 2022 -2.67 Mn
Dec 31, 2021 2.50 Mn
API Access

NeuroSense Therapeutics Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income&ticker=NRSN&period=max&api_key=YOUR_API_KEY